Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...
Despite a severe flu season, fewer Americans are getting flu shots, particularly children. Only 43% of eligible kids were ...